Selank mastery course
Unit 5 of 11

The immune inheritance

Selank preserves the entire tuftsin sequence and has immune activity of its own.

What Selank kept from its immune ancestor

Selank preserves the entire tuftsin sequence and has immune activity of its own. Studies report that it silences IL-6 gene expression in patients' cultured blood cells, shifts the Th1/Th2 cytokine balance in treated patients, induces interferon, and shows antiviral activity against influenza in the lab. Whether any of that runs through the same receptor pathway as its phagocytosis-stimulating parent is untested.

This unit covers the immune pillar honestly: it is mechanistically interesting and lineage-consistent, but it is not an approved indication anywhere and should be taught as a translational hypothesis, not a clinical claim.

Key terms

A retained immune signature

Selank's N-terminus is the intact tuftsin sequence, which is why immune endpoints were tested at all. Spleen gene-expression studies after Selank show changes across dozens of inflammation-related genes: activity the peptide demonstrably has, whatever pathway carries it.

Immune gene changes after Selank
Blunt activation versus selective shift

The pattern is selective rather than a blunt immune activation. Selank shifts a specific set of chemokine and cytokine genes, silences IL-6 gene expression in blood cells taken from symptomatic patients but not from healthy donors, and induces interferon without driving up the classic pro-inflammatory cytokine TNF-alpha. That selectivity is what makes the immune story interesting rather than alarming. Note the route mismatch worth holding onto: the spleen result came from a single intraperitoneal injection in mice, not from the registered intranasal route.

AdvancedWhy the tuftsin core predicts this

Tuftsin's job is to activate phagocytes and, through its receptor neuropilin-1, to nudge macrophages and microglia toward an anti-inflammatory M2 state. That receptor work was done on tuftsin itself, in mouse microglia, and no fetched source tests the same pathway for Selank. So the honest statement is two-part: Selank has documented immune-gene activity, and whether it inherits tuftsin's receptor mechanism along with tuftsin's sequence is an open question rather than an expectation the data support.


The IL-6 finding, read precisely


The antiviral signal


Reading the immune story responsibly


Where the immune effects show up